Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Large Scandinavian Trial Finds No Benefit of Aspirin After Treatment of Colorectal Cancer Liver Metastases

Colorectal cancer is one of the most common cancers worldwide, and up to half of patients develop liver metastases during the course of their disease. For these patients, surgery, sometimes combined with local ablative treatment, is the main potentially curative option. However, the risk of cancer recurrence remains high. The ASAC trial was therefore designed to determine whether aspirin, given after curative-intent treatment of liver metastases, could reduce the risk of recurrence.

October 2, 2026


October 2 2026

October 1 2026

September 30 2026

September 29 2026

September 28 2026

September 27 2026

September 25 2026

September 24 2026

September 23 2026

September 22 2026

September 21 2026

September 18 2026